Thinking Out Loud: March 2025

Thinking Out Loud: March 2025

March of the Teenage B Cells BCR are Like Teenagers I remember teenagers. I suppose that the last phase of teen development prepares you for their departure, and then they are gone… Hopefully, the memories of their sweet, former personalities will last longer than the...
Thinking Out Loud: February 2025

Thinking Out Loud: February 2025

We know, and We Care There is not a lot of room in the TOL (Thinking out Loud) Newsletter to share our feelings about the news in the USA, but we want you to know that we ARE aware, and we REALLY CARE about the negative impact of recent...
Thinking Out Loud: January 2025

Thinking Out Loud: January 2025

Applying Immunoinformatics to Animal Health We were thrilled to have a visit by Julia Baker (U of Minn Vet School) last week! She gave a terrific talk to the Epi-team on the evolution of Porcine Reproductive and Respiratory Syndrome virus (PRRSV). PRRSV is a...
Thinking Out Loud: December 2024

Thinking Out Loud: December 2024

Even more Fearless in 2025 2024 was a year of transformation and momentum for us—a real steppingstone to EpiVax 2.0. We are grateful to our new CEO, Rich-Henry Schabowsky, for creating a work environment where innovation moves at a human pace. Because together, we...
Thinking Out Loud: November 2024

Thinking Out Loud: November 2024

Talking out loud to myself (and about 7000 friends) It’s the time of year for gratitude As we approach the season of gratitude, I would like to THANK YOU, our colleagues in the immunogenicity space, who are “Science Forward”....
Thinking Out Loud: October 2024

Thinking Out Loud: October 2024

October is Rocking! Off to Amsterdam and Stockholm EpiVax Sets the Standards for the Generic Drug Industry Ok . . .  that’s an over-the-top headline! But read the press release! It reflects our excitement about our new contract with...